Home
About
FAQ
History (31)
Bortezomib added to daunorubicin and cytarabine during induction therapy and to intermediate-dose cytarabine for consolidation in patients with previously untreated acute myeloid leukemia age 60 to 75 years: CALGB (Alliance) study 10502.
Psychometrics
Plasma metabolomic profiles associated with chronic distress in women.
Oral health and quality of life of migrant and seasonal farmworkers in North Carolina.
Race differences in access to health care and disparities in incident chronic kidney disease in the US.
See All 31 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
vCard
Download vCard